Coming into the trading week that was, the S&P 500 (SPX) completed two up weeks in a row, and began the trading week with a surge above 3,000. This was an ideal set-up for the remainder of the trading week and one that was absent any anticipated geopolitical turbulence. Investors would be considering, for the most part, earnings and certain…
Breadth, Headlines, Trade, Earnings…All Improving?
A financial market resource for the every-day investor and trader.
-
Weekly State of the Market: Seasonal Tide Is Turning Bullish
Seth Golden, , Research Reports, 0
“One-half of life is luck; the other half is discipline — and that’s the important half, for without discipline...
-
J.C. Penney Downgraded: Nike Partnership Not A Savior For The Retailer
Seth Golden, , Research Reports, 0
After several reiterations in the last week of trading, on January 18, 2017 Credit Suisse’s Christian Buss has downgraded J.C. Penney...
-
Weekly State of the Market: WHAT IF,…IT’S. ALREADY. PRICED…?
Seth Golden, , Research Reports, 0
While we are forgoing our traditional State of the Market recording and process, please review our latest video (link...
-
COVID-19 Europe: J.P. Morgan
Seth Golden, , Research Reports, 0
Over the weekend the COVID-19 situation improved all the EU5 countries. Not only did the growth in net active...
-
The Leuthold Group: Putting The “Sahm Rule” To The Test
Seth Golden, , Research Reports, 0
In January, the “inventor” of the yield-curve indicator—Campbell Harvey of Duke University—suggested that the inversion of the 10Y/3M spread...
-
J.P. Morgan Tackles Election Implications For Investors
Seth Golden, , Research Reports, 0
US Equity Strategy Election Implications for Equities, Democrat AgendaWinners and Losers With US election only a few months away,...
-
-
Morgan Stanley Healthcare Conference: Dr. Scott Gottlieb
Seth Golden, , Research Reports, 0
To kick off the MS Global Healthcare Conference, onSeptember 14, Risinger and Harrison hosted former FDACommissioner Dr. Scott Gottlieb...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00